Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
Cephalalgia. 2009.
PMID: 19811503
Clinical Trial.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Search Results
22 results
Results by year
Citations
2
articles
found by citation matching
Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
Clin Drug Investig. 2009.
PMID: 19366274
Clinical Trial.
Search results
Page 1
Frovatriptan review.
Expert Opin Pharmacother. 2007 Dec;8(17):3029-33. doi: 10.1517/14656566.8.17.3029.
Expert Opin Pharmacother. 2007.
PMID: 18001261
Review.
Frovatriptan belongs to the triptan compounds used for the acute treatment of migraine. Its affinity for the migraine-specific serotonin 5HT1B-receptors is highest in the class. ...For example, for the short-term prophylaxis of menstrual …
Frovatriptan belongs to the triptan compounds used for the acute treatment of migraine. Its affinity for the migraine-s …
Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
Cephalalgia. 2009 Nov;29(11):1133-48. doi: 10.1111/j.1468-2982.2009.01840.x.
Cephalalgia. 2009.
PMID: 19811503
Clinical Trial.
The efficacy of a 6-day regimen of frovatriptan for menstrual migraine (MM; attacks starting on day -2 to +3 of menses) prevention in women with difficult-to-treat MM was assessed. ...When migraine occurred, severity was reduced with frovatri …
The efficacy of a 6-day regimen of frovatriptan for menstrual migraine (MM; attacks starting on day -2 to +3 of menses) …
Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
Headache. 2009 Oct;49(9):1283-97. doi: 10.1111/j.1526-4610.2009.01509.x. Epub 2009 Sep 14.
Headache. 2009.
PMID: 19751371
Clinical Trial.
OBJECTIVE: This post hoc subgroup analysis evaluated scheduled short-term preventive frovatriptan therapy for women with migraine occurring exclusively in association with menstruation (occurring day -2 to +3; day 1 = menses start, no …
OBJECTIVE: This post hoc subgroup analysis evaluated scheduled short-term preventive frovatriptan therapy for wo …
A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
Neurology. 2004 Jul 27;63(2):261-9. doi: 10.1212/01.wnl.0000134620.30129.d6.
Neurology. 2004.
PMID: 15277618
Clinical Trial.
Frovatriptan is a new selective 5HT(1B/1D) receptor agonist indicated for short-term management of migraine. ...The findings are consistent with the long duration of action and good tolerability of frovatriptan observed in short-term …
Frovatriptan is a new selective 5HT(1B/1D) receptor agonist indicated for short-term management of migraine. ... …
Prevention and treatment of menstrual migraine.
Drugs. 2010 Oct 1;70(14):1799-818. doi: 10.2165/11538090-000000000-00000.
Drugs. 2010.
PMID: 20836574
Review.
Menstruation is a significant risk factor for migraine, with attacks most likely to occur on or between 2 days before the onset of menstruation and the first 3 days of bleeding. ...There is grade B evidence of efficacy for short-term prophylaxis …
Menstruation is a significant risk factor for migraine, with attacks most likely to occur on or between 2 days before the onse …
Triptans in prevention of menstrual migraine: a systematic review with meta-analysis.
J Headache Pain. 2013 Jan 30;14(1):7. doi: 10.1186/1129-2377-14-7.
J Headache Pain. 2013.
PMID: 23565873
Free PMC article.
Randomized clinical trials (RCT) assessing the efficacy and tolerability of triptans compared with placebo as short-term prophylaxis of menstrual migraine (MM) were systematically reviewed in this study. Triptans, which interfere with the pathogenesis …
Randomized clinical trials (RCT) assessing the efficacy and tolerability of triptans compared with placebo as short-term proph …
Menstrual Migraine and Treatment Options: Review.
Headache. 2017 Feb;57(2):194-208. doi: 10.1111/head.12978. Epub 2016 Dec 2.
Headache. 2017.
PMID: 27910087
Review.
Menstrual migraine (MM) is divided into pure MM and menstrually related migraine. Pure MM attacks occur only with menstruation and have a prevalence of 1%. ...For short-term prophylaxis, triptans, non-triptans, or combinations are …
Menstrual migraine (MM) is divided into pure MM and menstrually related migraine. Pure MM attacks occur only wit …
Comparative efficacy of different treatments for menstrual migraine: a systematic review and network meta-analysis.
J Headache Pain. 2023 Jul 3;24(1):81. doi: 10.1186/s10194-023-01625-x.
J Headache Pain. 2023.
PMID: 37400775
Free PMC article.
BACKGROUND: Menstrual migraine is a subtype of migraine disease that is typically more disabling, longer-lasting, and more challenging to treat. ...CONCLUSIONS: These findings suggest that frovatriptan 2.5 mg twice daily was best for short-te …
BACKGROUND: Menstrual migraine is a subtype of migraine disease that is typically more disabling, longer-lasting, and m …
Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
Gend Med. 2010 Apr;7(2):88-108. doi: 10.1016/j.genm.2010.04.006.
Gend Med. 2010.
PMID: 20435272
BACKGROUND: Triptans are a recommended first-line treatment for moderate to severe migraine. OBJECTIVE: Using clinical trial data, we evaluated the safety and tolerability of frovatriptan as acute treatment (AT) and as short-term preventive (STP …
BACKGROUND: Triptans are a recommended first-line treatment for moderate to severe migraine. OBJECTIVE: Using clinical trial data, we …
Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
Headache. 2009 Oct;49(9):1298-314. doi: 10.1111/j.1526-4610.2009.01513.x.
Headache. 2009.
PMID: 19788471
Clinical Trial.
OBJECTIVE: To assess the safety and tolerability profile of the 5-HT(1B/1D) agonist frovatriptan (Frova(R), Endo Pharmaceuticals Inc., Chadds Ford, PA, USA) when used as a 6-day regimen for the short-term prevention of menstrual migraine …
OBJECTIVE: To assess the safety and tolerability profile of the 5-HT(1B/1D) agonist frovatriptan (Frova(R), Endo Pharmaceuticals Inc. …
Cite